首页 > 最新文献

African Journal of Thoracic and Critical Care Medicine最新文献

英文 中文
CASE REPORT: Mycobacterium tuberculosis pericardial cyst present ing as right heart failure in an immunocompromised patient. 病例报告:结核分枝杆菌心包囊肿表现为右心衰的免疫功能低下的病人。
Q3 Medicine Pub Date : 2025-09-04 eCollection Date: 2025-01-01 DOI: 10.7196/AJTCCM.2025.v31i3.2969
T K Shozi, N Mvelase, K Swe Swe-Han
{"title":"CASE REPORT: <i>Mycobacterium tuberculosis</i> pericardial cyst present ing as right heart failure in an immunocompromised patient.","authors":"T K Shozi, N Mvelase, K Swe Swe-Han","doi":"10.7196/AJTCCM.2025.v31i3.2969","DOIUrl":"10.7196/AJTCCM.2025.v31i3.2969","url":null,"abstract":"","PeriodicalId":52847,"journal":{"name":"African Journal of Thoracic and Critical Care Medicine","volume":"31 3","pages":"e2969"},"PeriodicalIF":0.0,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12622872/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145551837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
First-line treatment of pulmonary sarcoidosis with prednisone or methotrexate. 强的松或甲氨蝶呤治疗肺结节病的一线治疗。
Q3 Medicine Pub Date : 2025-09-04 eCollection Date: 2025-01-01
D J Lamprecht
{"title":"First-line treatment of pulmonary sarcoidosis with prednisone or methotrexate.","authors":"D J Lamprecht","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":52847,"journal":{"name":"African Journal of Thoracic and Critical Care Medicine","volume":"31 3","pages":"e4189"},"PeriodicalIF":0.0,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12622874/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145551859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Silicosis disease burden in Zambian ex-copper miners continues to persist: Need for policy and programmatic reform to address ongoing challenges. 赞比亚前铜矿工人的矽肺病负担继续存在:需要进行政策和方案改革,以应对当前的挑战。
Q3 Medicine Pub Date : 2025-09-04 eCollection Date: 2025-01-01 DOI: 10.7196/AJTCCM.2025.v31i3.4077
Mohamed F Jeebhay
{"title":"Silicosis disease burden in Zambian ex-copper miners continues to persist: Need for policy and programmatic reform to address ongoing challenges.","authors":"Mohamed F Jeebhay","doi":"10.7196/AJTCCM.2025.v31i3.4077","DOIUrl":"10.7196/AJTCCM.2025.v31i3.4077","url":null,"abstract":"","PeriodicalId":52847,"journal":{"name":"African Journal of Thoracic and Critical Care Medicine","volume":"31 3","pages":"79"},"PeriodicalIF":0.0,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12622870/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145551898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Silicosis in Zambian ex-copper miners: A cross-sectional study. 赞比亚前铜矿工人矽肺病:一项横断面研究。
Q3 Medicine Pub Date : 2025-09-04 eCollection Date: 2025-01-01 DOI: 10.7196/AJTCCM.2025.v31i3.2985
J M teWaterNaude, K Ngosa, M Chakulimba, R Ehrlich
<p><strong>Background: </strong>Dust exposure in copper mining, an important industry in Africa, poses a risk of silicosis and pulmonary tuberculosis (TB). Despite a number of reports on silicosis in Zambian copper miners since the 1960s, there has been no published report on silicosis prevalence.</p><p><strong>Objectives: </strong>To determine the prevalence of silicosis and related radiological abnormalities in Zambian copper miners.</p><p><strong>Methods: </strong>A cross-sectional analysis was conducted of 496 ex-copper miners' chest X-rays (CXRs) taken at the Occupational Health and Safety Institute in Kitwe, Zambia, between October 2019 and September 2020. Two experienced readers classified anonymised CXRs by consensus using the International Labour Organization (ILO) classification system for pneumoconiosis. The association between CXR outcomes and occupational variables, adjusting for age, was analysed using logistic regression.</p><p><strong>Results: </strong>A total of 472 records were analysable. Of the miners, 82% were from seven companies across six mining districts, with most having worked in Kitwe and Chingola. Median service length was 25.4 years and median age 62.8 years. Silicosis of nodular profusion >ILO 1/0 was found in 8.3% (95% confidence interval (CI) 5.9 - 11.1), with ILO categories 1 and >2 comprising 4.9% and 3.4%, respectively. Silicotuberculosis was present in 4.0%. Exposure-response relationships between silicosis and occupational metrics were weak with wide CIs. Other CXR abnormalities were features suggestive of TB (16.5%; 95% CI 13.3 - 20.2) and cardiomegaly (19.3%; 95% CI 15.8 - 23.1). Adjusting for age, TB was strongly associated with silicosis (odds ratio (OR) 6.0; 95% CI 3.0 - 11.9) but unrelated to service length. Cardiomegaly was associated with service length after adjustment for age (OR 1.38; 95% CI 0.94 - 2.10).</p><p><strong>Conclusion: </strong>The prevalence of silicosis in Zambian copper miners has not changed since the last (unpublished) study in 2012. Best-practice measurement of silica exposure in all copper mines and comprehensive surveillance of ex-miners for silicosis and TB are needed. The unexpected association of cardiomegaly with length of service warrants investigation of possible occupational risk.</p><p><strong>Study synopsis: </strong><b>What the study adds.</b> Although there have been previous reports on silicosis in Zambia, this is the first study of the prevalence of silicosis published in the open literature. It shows a persistence since 2012 of silicosis prevalence among ex-copper miners of 8%, with a substantial proportion of radiologically advanced disease.<b>Implications of the findings.</b> Zambia has a large and growing copper mining industry. Silicosis is a strong risk factor for pulmonary tuberculosis (TB), contributing to the elevated burden of TB among miners in Zambia. A multidisciplinary response of best-practice measurements of silica dust on all copper mines and countr
背景:铜矿开采是非洲一个重要的工业,其粉尘暴露存在矽肺病和肺结核(TB)的风险。尽管自20世纪60年代以来有许多关于赞比亚铜矿工人矽肺病的报道,但没有关于矽肺病患病率的发表报告。目的:了解赞比亚铜矿工人矽肺患病率及相关放射学异常。方法:对2019年10月至2020年9月在赞比亚基特韦职业健康与安全研究所拍摄的496名前铜矿工人的胸部x光片(cxr)进行横断面分析。两位经验丰富的读者通过协商一致使用国际劳工组织(ILO)尘肺病分类系统对匿名cxr进行分类。经年龄调整后,使用逻辑回归分析CXR结果与职业变量之间的关系。结果:共可分析记录472份。在这些矿工中,82%来自6个矿区的7家公司,其中大多数曾在基特韦和钦戈拉工作。中位服务年限为25.4年,中位年龄为62.8岁。8.3%(95%可信区间(CI) 5.9 - 11.1)发现结节性弥漫型矽肺病>ILO 1/0,其中ILO 1类和>2类分别占4.9%和3.4%。4.0%为矽肺病。矽肺病与职业指标的暴露-反应关系较弱,ci较宽。其他CXR异常为提示结核(16.5%,95% CI 13.3 - 20.2)和心脏肥大(19.3%,95% CI 15.8 - 23.1)的特征。调整年龄后,结核病与矽肺密切相关(优势比(OR) 6.0;95% CI 3.0 - 11.9),但与服务时长无关。调整年龄后,心脏肥大与服役时间相关(OR 1.38; 95% CI 0.94 - 2.10)。结论:自2012年最后一项(未发表的)研究以来,赞比亚铜矿工人矽肺病的患病率没有改变。需要对所有铜矿的二氧化硅暴露量进行最佳实践测量,并对前矿工进行矽肺病和结核病的全面监测。心脏肥大与服役时间的意外关联值得对可能的职业风险进行调查。研究简介:研究补充了什么。虽然以前有关于赞比亚矽肺病的报道,但这是首次在公开文献中发表的矽肺病患病率研究。报告显示,自2012年以来,前铜矿工人矽肺病的患病率一直保持在8%,其中很大一部分是放射学晚期疾病。研究结果的含义。赞比亚拥有规模庞大且不断增长的铜矿采矿业。矽肺是肺结核(TB)的一个强大危险因素,导致赞比亚矿工结核病负担增加。需要对所有铜矿二氧化硅粉尘的最佳实践测量和全国范围内对前矿工矽肺病和结核病的医疗监测作出多学科反应,作为一级预防的基础。
{"title":"Silicosis in Zambian ex-copper miners: A cross-sectional study.","authors":"J M teWaterNaude, K Ngosa, M Chakulimba, R Ehrlich","doi":"10.7196/AJTCCM.2025.v31i3.2985","DOIUrl":"10.7196/AJTCCM.2025.v31i3.2985","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Dust exposure in copper mining, an important industry in Africa, poses a risk of silicosis and pulmonary tuberculosis (TB). Despite a number of reports on silicosis in Zambian copper miners since the 1960s, there has been no published report on silicosis prevalence.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;To determine the prevalence of silicosis and related radiological abnormalities in Zambian copper miners.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A cross-sectional analysis was conducted of 496 ex-copper miners' chest X-rays (CXRs) taken at the Occupational Health and Safety Institute in Kitwe, Zambia, between October 2019 and September 2020. Two experienced readers classified anonymised CXRs by consensus using the International Labour Organization (ILO) classification system for pneumoconiosis. The association between CXR outcomes and occupational variables, adjusting for age, was analysed using logistic regression.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 472 records were analysable. Of the miners, 82% were from seven companies across six mining districts, with most having worked in Kitwe and Chingola. Median service length was 25.4 years and median age 62.8 years. Silicosis of nodular profusion &gt;ILO 1/0 was found in 8.3% (95% confidence interval (CI) 5.9 - 11.1), with ILO categories 1 and &gt;2 comprising 4.9% and 3.4%, respectively. Silicotuberculosis was present in 4.0%. Exposure-response relationships between silicosis and occupational metrics were weak with wide CIs. Other CXR abnormalities were features suggestive of TB (16.5%; 95% CI 13.3 - 20.2) and cardiomegaly (19.3%; 95% CI 15.8 - 23.1). Adjusting for age, TB was strongly associated with silicosis (odds ratio (OR) 6.0; 95% CI 3.0 - 11.9) but unrelated to service length. Cardiomegaly was associated with service length after adjustment for age (OR 1.38; 95% CI 0.94 - 2.10).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;The prevalence of silicosis in Zambian copper miners has not changed since the last (unpublished) study in 2012. Best-practice measurement of silica exposure in all copper mines and comprehensive surveillance of ex-miners for silicosis and TB are needed. The unexpected association of cardiomegaly with length of service warrants investigation of possible occupational risk.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Study synopsis: &lt;/strong&gt;&lt;b&gt;What the study adds.&lt;/b&gt; Although there have been previous reports on silicosis in Zambia, this is the first study of the prevalence of silicosis published in the open literature. It shows a persistence since 2012 of silicosis prevalence among ex-copper miners of 8%, with a substantial proportion of radiologically advanced disease.&lt;b&gt;Implications of the findings.&lt;/b&gt; Zambia has a large and growing copper mining industry. Silicosis is a strong risk factor for pulmonary tuberculosis (TB), contributing to the elevated burden of TB among miners in Zambia. A multidisciplinary response of best-practice measurements of silica dust on all copper mines and countr","PeriodicalId":52847,"journal":{"name":"African Journal of Thoracic and Critical Care Medicine","volume":"31 3","pages":"e2985"},"PeriodicalIF":0.0,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12622876/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145551924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation and determinants of asthma control among adult patients with asthma attending the Johannesburg academic respiratory clinics: A cross-sectional study. 约翰内斯堡学术呼吸诊所成年哮喘患者哮喘控制的评估和决定因素:一项横断面研究。
Q3 Medicine Pub Date : 2025-09-04 eCollection Date: 2025-01-01 DOI: 10.7196/AJTCCM.2025.v31i3.2200
G J Titus, J Clark-Buchner, J Coetzee, Y Mbule, S Moodley, V Nephalama, T Seroka, T Stransky, L Wagener, A Graham, M L Wong, E J Shaddock

Background: The prevalence of asthma in South Africa is among the highest in Africa, but little research has been done regarding levels of asthma control and associated determinants.

Objectives: To explore level of asthma control and perceived risk factors associated with poor control in adult patients with asthma attending respiratory clinics at three major hospitals in Johannesburg.

Methods: This was a quantitative, descriptive, cross-sectional study of all adult patients attending the clinics. Participants were given a three-section self-reporting survey, consisting of a demographic section, an Asthma Control Test (ACT) questionnaire, and an eight-item Morisky Medication Adherence Scale (MMAS-8) questionnaire.

Results: The prevalence of poor asthma control based on participants' ACT scores in this study was 71.3%. A significant linear regression was identified between the ACT and MMAS-8 scores in the uncontrolled asthma group. Significant associations between asthma control and the sociodemographic factors age, body mass index ≥25 and previous hospitalisation for exacerbation were found. No such associations existed for gender or level of education. In evaluating comorbidities, no significant association was found for hypertension, gastro-oesophageal reflux disease, sinusitis or diabetes mellitus. Of the patients, 89.3% used short-acting beta-agonists and 93.3% inhaled corticosteroids (ICSs); 58.7% were on combined long-acting beta-agonists and ICSs.

Conclusion: Asthma control in the study setting was poor. There was also an interesting inverse relationship between control and therapy adherence. Further research is needed to better understand the issues surrounding asthma control and to lay the groundwork for policies to benefit asthma patients in the future.

Study synopsis: What the study adds. This study adds to the data on asthma control and associated determinants in the adult population in South Africa (SA). Data are scarce, despite the known high prevalence of asthma in this population.Implications of the findings. The study outlines the fairly poor levels of asthma control in this population, even at a tertiary level. The outcomes reflected here provide motivation for further investigation into levels of asthma control in SA and in sub-Saharan Africa as a whole. This further investigation could ultimately impact on patient care and provide the basis of improved best practice for both patient and physician education.

背景:南非是非洲哮喘患病率最高的国家之一,但关于哮喘控制水平和相关决定因素的研究很少。目的:探讨在约翰内斯堡三家大医院呼吸科就诊的成年哮喘患者的哮喘控制水平和与控制不良相关的感知危险因素。方法:这是一项定量的、描述性的、横断面的研究,研究对象是所有到诊所就诊的成年患者。参与者被给予三部分的自我报告调查,包括人口统计部分、哮喘控制测试(ACT)问卷和8项莫里斯基药物依从性量表(MMAS-8)问卷。结果:在本研究中,基于参与者ACT评分的哮喘控制不良患病率为71.3%。在未控制哮喘组中,ACT和MMAS-8评分之间存在显著的线性回归。发现哮喘控制与社会人口学因素、年龄、体重指数≥25和既往因急性发作住院治疗有显著相关性。性别或教育水平之间不存在这种联系。在评估合并症时,没有发现高血压、胃食管反流病、鼻窦炎或糖尿病的显著相关性。89.3%的患者使用短效β激动剂,93.3%的患者使用吸入性皮质类固醇(ICSs);58.7%的患者联合使用长效受体激动剂和iss。结论:研究环境中哮喘控制较差。在控制和治疗依从性之间也有一个有趣的反比关系。需要进一步的研究来更好地了解哮喘控制周围的问题,并为未来有利于哮喘患者的政策奠定基础。研究简介:研究补充了什么。这项研究增加了关于南非成年人哮喘控制和相关决定因素的数据。尽管已知这一人群的哮喘患病率很高,但数据很少。研究结果的含义。该研究概述了这一人群的哮喘控制水平相当差,甚至在三级水平。这里反映的结果为进一步研究南非和整个撒哈拉以南非洲地区的哮喘控制水平提供了动力。这项进一步的调查可能最终影响患者护理,并为患者和医生教育提供改进的最佳实践基础。
{"title":"Evaluation and determinants of asthma control among adult patients with asthma attending the Johannesburg academic respiratory clinics: A cross-sectional study.","authors":"G J Titus, J Clark-Buchner, J Coetzee, Y Mbule, S Moodley, V Nephalama, T Seroka, T Stransky, L Wagener, A Graham, M L Wong, E J Shaddock","doi":"10.7196/AJTCCM.2025.v31i3.2200","DOIUrl":"10.7196/AJTCCM.2025.v31i3.2200","url":null,"abstract":"<p><strong>Background: </strong>The prevalence of asthma in South Africa is among the highest in Africa, but little research has been done regarding levels of asthma control and associated determinants.</p><p><strong>Objectives: </strong>To explore level of asthma control and perceived risk factors associated with poor control in adult patients with asthma attending respiratory clinics at three major hospitals in Johannesburg.</p><p><strong>Methods: </strong>This was a quantitative, descriptive, cross-sectional study of all adult patients attending the clinics. Participants were given a three-section self-reporting survey, consisting of a demographic section, an Asthma Control Test (ACT) questionnaire, and an eight-item Morisky Medication Adherence Scale (MMAS-8) questionnaire.</p><p><strong>Results: </strong>The prevalence of poor asthma control based on participants' ACT scores in this study was 71.3%. A significant linear regression was identified between the ACT and MMAS-8 scores in the uncontrolled asthma group. Significant associations between asthma control and the sociodemographic factors age, body mass index ≥25 and previous hospitalisation for exacerbation were found. No such associations existed for gender or level of education. In evaluating comorbidities, no significant association was found for hypertension, gastro-oesophageal reflux disease, sinusitis or diabetes mellitus. Of the patients, 89.3% used short-acting beta-agonists and 93.3% inhaled corticosteroids (ICSs); 58.7% were on combined long-acting beta-agonists and ICSs.</p><p><strong>Conclusion: </strong>Asthma control in the study setting was poor. There was also an interesting inverse relationship between control and therapy adherence. Further research is needed to better understand the issues surrounding asthma control and to lay the groundwork for policies to benefit asthma patients in the future.</p><p><strong>Study synopsis: </strong><b>What the study adds.</b> This study adds to the data on asthma control and associated determinants in the adult population in South Africa (SA). Data are scarce, despite the known high prevalence of asthma in this population.<b>Implications of the findings.</b> The study outlines the fairly poor levels of asthma control in this population, even at a tertiary level. The outcomes reflected here provide motivation for further investigation into levels of asthma control in SA and in sub-Saharan Africa as a whole. This further investigation could ultimately impact on patient care and provide the basis of improved best practice for both patient and physician education.</p>","PeriodicalId":52847,"journal":{"name":"African Journal of Thoracic and Critical Care Medicine","volume":"31 3","pages":"e2200"},"PeriodicalIF":0.0,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12622878/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145551893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pulmonary rehabilitation across Africa: A continental evaluation of healthcare providers' awareness, availability and utilisation, and barriers to access. 整个非洲的肺部康复:对医疗保健提供者的认识、可得性和利用以及获取障碍的大陆评估。
Q3 Medicine Pub Date : 2025-09-04 eCollection Date: 2025-01-01 DOI: 10.7196/AJTCCM.2025.v31i3.2516
M Isiagi, K J Okop, K Dikgomo, F M Bickton, J Rylance, E Akurut, J Gizamba, R N van Zyl-Smit

Background: In Africa, with a high burden of chronic obstructive pulmonary disease (COPD), access to medication and availability and use of pulmonary rehabilitation (PR) intervention, including awareness of its effectiveness, remain limited.

Objectives: To evaluate the extent of clinical awareness and knowledge of and support for PR among healthcare providers, and to identify barriers to PR in Africa.

Methods: A comprehensive electronic survey was conducted to assess healthcare providers (HCPs)' beliefs about, knowledge, awareness and utilisation of, and access to PR in Africa, to inform strategies and policies for improved COPD prevention. The survey was adapted and validated for the African context through expert review and pilot testing with regional practitioners. It was then distributed to HCPs in clinical practice through the networks of the South African Thoracic Society and the Pan African Thoracic Society across Africa.

Results: Data were received from 108 HCPs representing diverse disciplines across rural and urban locations in 23 African countries (response rate 56%). The median (interquartile range) age was 41.0 (37.0 - 48.5) years, with no significant differences between the locations. Almost all the HCPs (98%) acknowledged the necessity of PR for severe pulmonary disease, and 58% expressed the need to improve their knowledge and skills in this area. Significant barriers such as under-reporting of symptoms by patients (74%) and a lack of easy access to spirometry (53%) were reported, hindering access to and diagnosis and rehabilitation of patients with COPD.

Conclusion: The substantial awareness and recognition of PR as an effective intervention for COPD and other chronic lung diseases across Africa is remarkable. It could indicate the feasible benefits that HCPs attach to implementing comprehensive PR in African settings. Equipping all HCPs with the requisite skills to implement an effective, locally acceptable PR programme will mitigate the burden of COPD in Africa.

Study synopsis: What the study adds. There is a paucity of recent studies in Africa that have addressed healthcare providers (HCPs)' knowledge of, attitudes to and beliefs about pulmonary rehabilitation (PR) or PR-related care activities. This study addresses that lack.Implications of the findings. The increasing recognition and acknowledgment of PR as a highly effective intervention for chronic obstructive respiratory disease and other chronic lung diseases across Africa is truly notable. It reflects the potential benefits that HCPs associate with implementing a comprehensive PR programme in African settings. Equipping all HCPs with the necessary skills to set up effective, locally accepted PR programmes will alleviate the burden of COPD in Africa.

背景:在慢性阻塞性肺病(COPD)负担沉重的非洲,药物的可及性以及肺康复(PR)干预措施的可得性和使用,包括对其有效性的认识仍然有限。目的:评估医疗保健提供者对PR的临床意识、知识和支持程度,并确定非洲PR的障碍。方法:进行了一项全面的电子调查,以评估非洲医疗保健提供者(HCPs)对PR的认识、认识、利用和获取的信念,为改善COPD预防的战略和政策提供信息。通过专家审查和区域从业人员的试点测试,对调查进行了调整和验证,以适应非洲的情况。然后通过南非胸科协会和泛非胸科协会在整个非洲的网络在临床实践中分发给HCPs。结果:收到了来自23个非洲国家农村和城市地区不同学科的108名医务人员的数据(回复率56%)。年龄中位数(四分位间距)为41.0(37.0 ~ 48.5)岁,各地区间无显著差异。几乎所有的医务人员(98%)都承认对严重肺部疾病进行PR治疗的必要性,58%的医务人员表示需要提高他们在这方面的知识和技能。据报道,严重的障碍,如患者少报症状(74%)和难以获得肺活量测定法(53%),阻碍了COPD患者的获得、诊断和康复。结论:整个非洲对PR作为COPD和其他慢性肺部疾病的有效干预措施的认识和认可是显著的。它可以表明卫生保健提供者在非洲环境中实施全面公共关系所带来的切实利益。为所有医务人员配备必要的技能,以实施有效的、当地可接受的公共关系规划,将减轻非洲慢性阻塞性肺病的负担。研究简介:研究补充了什么。最近在非洲缺乏关于卫生保健提供者(HCPs)对肺康复(PR)或与PR相关的护理活动的知识、态度和信念的研究。这项研究解决了这一不足。研究结果的含义。在非洲,越来越多的人认识到PR是治疗慢性阻塞性呼吸系统疾病和其他慢性肺部疾病的一种非常有效的干预措施,这确实值得注意。它反映了医务人员与在非洲环境中实施全面公关规划有关的潜在利益。为所有医务人员配备必要的技能,以建立有效的、当地接受的公共关系规划,将减轻非洲慢性阻塞性肺病的负担。
{"title":"Pulmonary rehabilitation across Africa: A continental evaluation of healthcare providers' awareness, availability and utilisation, and barriers to access.","authors":"M Isiagi, K J Okop, K Dikgomo, F M Bickton, J Rylance, E Akurut, J Gizamba, R N van Zyl-Smit","doi":"10.7196/AJTCCM.2025.v31i3.2516","DOIUrl":"10.7196/AJTCCM.2025.v31i3.2516","url":null,"abstract":"<p><strong>Background: </strong>In Africa, with a high burden of chronic obstructive pulmonary disease (COPD), access to medication and availability and use of pulmonary rehabilitation (PR) intervention, including awareness of its effectiveness, remain limited.</p><p><strong>Objectives: </strong>To evaluate the extent of clinical awareness and knowledge of and support for PR among healthcare providers, and to identify barriers to PR in Africa.</p><p><strong>Methods: </strong>A comprehensive electronic survey was conducted to assess healthcare providers (HCPs)' beliefs about, knowledge, awareness and utilisation of, and access to PR in Africa, to inform strategies and policies for improved COPD prevention. The survey was adapted and validated for the African context through expert review and pilot testing with regional practitioners. It was then distributed to HCPs in clinical practice through the networks of the South African Thoracic Society and the Pan African Thoracic Society across Africa.</p><p><strong>Results: </strong>Data were received from 108 HCPs representing diverse disciplines across rural and urban locations in 23 African countries (response rate 56%). The median (interquartile range) age was 41.0 (37.0 - 48.5) years, with no significant differences between the locations. Almost all the HCPs (98%) acknowledged the necessity of PR for severe pulmonary disease, and 58% expressed the need to improve their knowledge and skills in this area. Significant barriers such as under-reporting of symptoms by patients (74%) and a lack of easy access to spirometry (53%) were reported, hindering access to and diagnosis and rehabilitation of patients with COPD.</p><p><strong>Conclusion: </strong>The substantial awareness and recognition of PR as an effective intervention for COPD and other chronic lung diseases across Africa is remarkable. It could indicate the feasible benefits that HCPs attach to implementing comprehensive PR in African settings. Equipping all HCPs with the requisite skills to implement an effective, locally acceptable PR programme will mitigate the burden of COPD in Africa.</p><p><strong>Study synopsis: </strong><b>What the study adds.</b> There is a paucity of recent studies in Africa that have addressed healthcare providers (HCPs)' knowledge of, attitudes to and beliefs about pulmonary rehabilitation (PR) or PR-related care activities. This study addresses that lack.<b>Implications of the findings.</b> The increasing recognition and acknowledgment of PR as a highly effective intervention for chronic obstructive respiratory disease and other chronic lung diseases across Africa is truly notable. It reflects the potential benefits that HCPs associate with implementing a comprehensive PR programme in African settings. Equipping all HCPs with the necessary skills to set up effective, locally accepted PR programmes will alleviate the burden of COPD in Africa.</p>","PeriodicalId":52847,"journal":{"name":"African Journal of Thoracic and Critical Care Medicine","volume":"31 3","pages":"e2156"},"PeriodicalIF":0.0,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12622875/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145551906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
South African Thoracic Society consensus statement on transbronchial lung cryobiopsy for interstitial lung disease. 南非胸科学会关于间质性肺病经支气管肺低温活检的共识声明。
Q3 Medicine Pub Date : 2025-09-04 eCollection Date: 2025-01-01 DOI: 10.7196/AJTCCM.2025.v31i3.3748
C F N Koegelenberg, N Singh, A Esmail, R Hofmeyr, A Graham, B W Allwood, U Lalla, P Goussard, K Dheda

Background: Surgical lung biopsy (SLB), performed via open lung biopsy or video-assisted thoracoscopic surgery, has traditionally been the gold standard for diagnosing interstitial lung disease (ILD) when histological confirmation is necessary. Transbronchial forceps biopsy, while less invasive, often yields small, artifact-prone specimens that are insufficient for conclusive histopathological analysis. Transbronchial lung cryobiopsy (TBLC) has emerged as a minimally invasive alternative, offering a higher diagnostic yield and superior tissue integrity due to the retrieval of larger, en bloc samples. International societies currently conditionally recommended TBLC as a potential first-line diagnostic tool for ILD, citing its favourable safety profile and diagnostic performance.

Technique procedural environment and complications: TBLC may be performed via flexible bronchoscopy with or without an artificial airway. When an artificial airway is used, general anaesthesia is administered, and a supraglottic device or endotracheal tube facilitates bronchoscope and blocker access. Without an artificial airway, the procedure is conducted under conscious sedation using an oral bite guard. A bronchial blocker is deployed to control bleeding, and biopsies are obtained under fluoroscopic guidance with freezing times of 6 - 10 seconds. At least four adequate samples (>5 mm) are collected. Post-procedure care includes positioning the patient with the biopsied lung in the dependent position and performing imaging to detect pneumothorax. While bleeding and pneumothorax are potential risks, they are generally manageable. Definitive exclusion criteria for TBLC have not yet been established, but characteristics such as severely impaired lung function, pulmonary hypertension and significant comorbidity are associated with adverse events.

Conclusion: Although TBLC yields marginally lower diagnostic rates compared with SLB, it remains a cost-effective and safer alternative, particularly in resource-limited settings. The South African Thoracic Society strongly advocates for TBLC as the first-line diagnostic modality in all cases of ILD, where histology is required, provided there are no contraindications. This recommendation is based on the lower cost and morbidity associated with TBLC compared with SLB. An exception is made for patients with non-diffuse or non-peribronchiolar disease who are suitable candidates for SLB and where the procedure is readily available. Strengthening local capacity and expertise in TBLC is crucial for improving ILD diagnostic accuracy in South Africa.

背景:外科肺活检(SLB),通过开放式肺活检或视频辅助胸腔镜手术进行,传统上是诊断间质性肺疾病(ILD)的金标准,当组织学证实是必要的。经支气管钳活检,虽然侵入性较小,但往往产生小的,容易产生伪影的标本,不足以进行结论性的组织病理学分析。经支气管肺低温活检(TBLC)已成为一种微创替代方法,由于检索更大的整体样本,可提供更高的诊断率和更好的组织完整性。国际社会目前有条件地推荐TBLC作为ILD的潜在一线诊断工具,理由是其良好的安全性和诊断性能。技术、操作环境和并发症:TBLC可通过柔性支气管镜进行,有或没有人工气道。当使用人工气道时,进行全身麻醉,声门上装置或气管内管便于支气管镜和阻断剂进入。在没有人工气道的情况下,手术是在使用口腔咬护器的清醒镇静下进行的。使用支气管阻滞剂控制出血,在透视引导下冷冻6 - 10秒进行活组织检查。至少收集四个足够的样品(bbb5毫米)。术后护理包括将活检后的患者置于依赖位置,并进行影像学检查以检测气胸。虽然出血和气胸是潜在的风险,但它们通常是可控的。TBLC的明确排除标准尚未建立,但肺功能严重受损、肺动脉高压和显著合并症等特征与不良事件相关。结论:尽管与SLB相比,TBLC的诊断率略低,但它仍然是一种具有成本效益和更安全的选择,特别是在资源有限的情况下。南非胸科学会强烈主张在没有禁忌症的情况下,在需要组织学检查的情况下,将TBLC作为所有ILD病例的一线诊断方式。这一建议是基于与SLB相比,TBLC的成本和发病率较低。非弥漫性或非细支气管周围疾病的患者是SLB的合适候选人,并且手术很容易获得。加强地方在TBLC方面的能力和专业知识对于提高南非ILD诊断的准确性至关重要。
{"title":"South African Thoracic Society consensus statement on transbronchial lung cryobiopsy for interstitial lung disease.","authors":"C F N Koegelenberg, N Singh, A Esmail, R Hofmeyr, A Graham, B W Allwood, U Lalla, P Goussard, K Dheda","doi":"10.7196/AJTCCM.2025.v31i3.3748","DOIUrl":"10.7196/AJTCCM.2025.v31i3.3748","url":null,"abstract":"<p><strong>Background: </strong>Surgical lung biopsy (SLB), performed via open lung biopsy or video-assisted thoracoscopic surgery, has traditionally been the gold standard for diagnosing interstitial lung disease (ILD) when histological confirmation is necessary. Transbronchial forceps biopsy, while less invasive, often yields small, artifact-prone specimens that are insufficient for conclusive histopathological analysis. Transbronchial lung cryobiopsy (TBLC) has emerged as a minimally invasive alternative, offering a higher diagnostic yield and superior tissue integrity due to the retrieval of larger, <i>en bloc</i> samples. International societies currently conditionally recommended TBLC as a potential first-line diagnostic tool for ILD, citing its favourable safety profile and diagnostic performance.</p><p><strong>Technique procedural environment and complications: </strong>TBLC may be performed via flexible bronchoscopy with or without an artificial airway. When an artificial airway is used, general anaesthesia is administered, and a supraglottic device or endotracheal tube facilitates bronchoscope and blocker access. Without an artificial airway, the procedure is conducted under conscious sedation using an oral bite guard. A bronchial blocker is deployed to control bleeding, and biopsies are obtained under fluoroscopic guidance with freezing times of 6 - 10 seconds. At least four adequate samples (>5 mm) are collected. Post-procedure care includes positioning the patient with the biopsied lung in the dependent position and performing imaging to detect pneumothorax. While bleeding and pneumothorax are potential risks, they are generally manageable. Definitive exclusion criteria for TBLC have not yet been established, but characteristics such as severely impaired lung function, pulmonary hypertension and significant comorbidity are associated with adverse events.</p><p><strong>Conclusion: </strong>Although TBLC yields marginally lower diagnostic rates compared with SLB, it remains a cost-effective and safer alternative, particularly in resource-limited settings. The South African Thoracic Society strongly advocates for TBLC as the first-line diagnostic modality in all cases of ILD, where histology is required, provided there are no contraindications. This recommendation is based on the lower cost and morbidity associated with TBLC compared with SLB. An exception is made for patients with non-diffuse or non-peribronchiolar disease who are suitable candidates for SLB and where the procedure is readily available. Strengthening local capacity and expertise in TBLC is crucial for improving ILD diagnostic accuracy in South Africa.</p>","PeriodicalId":52847,"journal":{"name":"African Journal of Thoracic and Critical Care Medicine","volume":"31 3","pages":"e3748"},"PeriodicalIF":0.0,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12622883/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145551926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular techniques v. conventional culture: Should there really be a debate? 分子技术与传统文化:真的应该有争论吗?
Q3 Medicine Pub Date : 2025-06-04 eCollection Date: 2025-01-01 DOI: 10.7196/AJTCCM.2025.v31i2.3653
S D Maasdorp, B van der Westhuizen
{"title":"Molecular techniques v. conventional culture: Should there really be a debate?","authors":"S D Maasdorp, B van der Westhuizen","doi":"10.7196/AJTCCM.2025.v31i2.3653","DOIUrl":"10.7196/AJTCCM.2025.v31i2.3653","url":null,"abstract":"","PeriodicalId":52847,"journal":{"name":"African Journal of Thoracic and Critical Care Medicine","volume":"31 2","pages":"e3653"},"PeriodicalIF":0.0,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12490501/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145234114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spotlight on lung health in operating theatre staff. 关注手术室工作人员的肺部健康。
Q3 Medicine Pub Date : 2025-06-04 eCollection Date: 2025-01-01 DOI: 10.7196/AJTCCM.2025.v31i2.3652
Mohamed F Jeebhay
{"title":"Spotlight on lung health in operating theatre staff.","authors":"Mohamed F Jeebhay","doi":"10.7196/AJTCCM.2025.v31i2.3652","DOIUrl":"10.7196/AJTCCM.2025.v31i2.3652","url":null,"abstract":"","PeriodicalId":52847,"journal":{"name":"African Journal of Thoracic and Critical Care Medicine","volume":"31 2","pages":"e3652"},"PeriodicalIF":0.0,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12490503/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145234042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular diagnostics improve the yield of diagnosis of community-acquired pneumonia and multidrug-resistant pathogens in hospitalised patients with HIV in a low-income setting. 分子诊断提高了低收入环境中住院艾滋病毒患者社区获得性肺炎和耐多药病原体的诊断率。
Q3 Medicine Pub Date : 2025-06-04 eCollection Date: 2025-01-01 DOI: 10.7196/AJTCCM.2025.v31i2.2415
W Worodria, A Andama, I Sanyu, D Orit, R Kwizera, A Sessolo, P Byanyima, J Zawedde, S Kaswabuli, E Mande, C Mukashyaka, F Semitala, A Cattamanchi, D R Boulware, L Huang

Background: Community-acquired pneumonia (CAP) remains an important cause of morbidity and mortality in people with HIV (PWH), and antimicrobial resistance (AMR) leads to poor treatment outcomes. Better tests are required to overcome the low sensitivity of sputum Gram stain and culture for pneumonia diagnosis. Molecular diagnostic tests rapidly detect respiratory pathogens and markers of AMR, but few studies have examined their role in PWH.

Objectives: To investigate the additional yield of the Biofire FilmArray Pneumonia Panel plus (FilmArrayPN-PCR), an automated nested multiplex polymerase chain reaction system, over culture for diagnosis of CAP, and determine clinical predictors of AMR in PWH.

Methods: We enrolled adult PWH hospitalised with cough <2 months in a prospective cohort in Kampala, Uganda. Participants provided expectorated sputum samples for testing by FilmArrayPN-PCR and culture. We performed drug susceptibility testing of cultured sputum isolates and detection of genetic markers of AMR on sputum by FilmArrayPN-PCR.

Results: The 107 participants enrolled had a median (interquartile range) age of 40 (31 - 46) years, 50.5% (n=54/107) were female, and 74.8% (n=80/107) had recent antibiotic use. The median duration of cough was 3 (1 - 4) weeks. FilmArrayPN-PCR increased the detection of respiratory pathogens by 64.5% (95% confidence interval (CI) 54.8 - 73.1; p<0.001) and detected AMR in 25.2% (n=27/107). Baseline room air oxygen saturation <92% (adjusted odds ratio (aOR) 9.20; 95% CI 2.52 - 33.57; p=0.001) and prior antibiotic use (aOR 4.14; 95% CI 1.04 - 16.51; p=0.04) were independent predictors of AMR.

Conclusion: FilmArrayPN-PCR increased the diagnostic yield of pathogens, and a low baseline oxygen saturation (<92%) and prior antibiotic use were associated with an increased risk of AMR in hospitalised PWH with CAP.

Study synopsis: What the study adds. The Biofire FilmArray Pneumonia Panel plus detected 64.5% more respiratory pathogens compared with culture, and detected antimicrobial resistance (AMR) genes in 25.2% of patients with HIV hospitalised with community-acquired pneumonia (CAP). Baseline room air oxygen saturation <92% and prior antibiotic use were associated with nine times and four times increased odds of AMR, respectively.Implications of the findings. Multiplex polymerase chain reaction (PCR) assays increase the speed of detection and diagnostic yield of respiratory pathogens and may be useful for diagnosis of AMR in hospitalised patients with HIV and CAP. The clinical implications of these findings should be evaluated further in prospective studies and cost-effectiveness studies to define the role of multiplex PCR tests in the patient care pathway.

背景:社区获得性肺炎(CAP)仍然是HIV感染者(PWH)发病和死亡的重要原因,而抗菌素耐药性(AMR)导致治疗结果不佳。需要更好的测试来克服痰革兰氏染色和培养对肺炎诊断的低敏感性。分子诊断技术可以快速检测呼吸道病原体和抗生素耐药性标志物,但很少有研究检测它们在PWH中的作用。目的:研究Biofire FilmArray肺炎Panel plus (FilmArrayPN-PCR)的额外产量,这是一种自动嵌套多重聚合酶链反应系统,用于CAP的诊断,并确定PWH中AMR的临床预测因素。结果:入选的107名参与者年龄中位数(四分位数范围)为40(31 - 46)岁,50.5% (n=54/107)为女性,74.8% (n=80/107)近期使用过抗生素。咳嗽持续时间中位数为3(1 ~ 4)周。FilmArrayPN-PCR使呼吸道病原体检出率提高64.5%(95%可信区间(CI) 54.8 ~ 73.1;结论:FilmArrayPN-PCR提高了病原体的诊断率,并降低了基线血氧饱和度(研究简介:研究补充的内容)。与培养相比,Biofire FilmArray肺炎小组plus检测到的呼吸道病原体多64.5%,并在25.2%的社区获得性肺炎(CAP)住院的HIV患者中检测到抗菌素耐药性(AMR)基因。基线室内空气氧饱和度研究结果的含义。多重聚合酶链反应(PCR)检测提高了呼吸道病原体的检测速度和诊断率,可能有助于诊断HIV和CAP住院患者的抗菌素耐药性。这些发现的临床意义应在前瞻性研究和成本效益研究中进一步评估,以确定多重PCR检测在患者护理途径中的作用。
{"title":"Molecular diagnostics improve the yield of diagnosis of community-acquired pneumonia and multidrug-resistant pathogens in hospitalised patients with HIV in a low-income setting.","authors":"W Worodria, A Andama, I Sanyu, D Orit, R Kwizera, A Sessolo, P Byanyima, J Zawedde, S Kaswabuli, E Mande, C Mukashyaka, F Semitala, A Cattamanchi, D R Boulware, L Huang","doi":"10.7196/AJTCCM.2025.v31i2.2415","DOIUrl":"10.7196/AJTCCM.2025.v31i2.2415","url":null,"abstract":"<p><strong>Background: </strong>Community-acquired pneumonia (CAP) remains an important cause of morbidity and mortality in people with HIV (PWH), and antimicrobial resistance (AMR) leads to poor treatment outcomes. Better tests are required to overcome the low sensitivity of sputum Gram stain and culture for pneumonia diagnosis. Molecular diagnostic tests rapidly detect respiratory pathogens and markers of AMR, but few studies have examined their role in PWH.</p><p><strong>Objectives: </strong>To investigate the additional yield of the Biofire FilmArray Pneumonia Panel plus (FilmArrayPN-PCR), an automated nested multiplex polymerase chain reaction system, over culture for diagnosis of CAP, and determine clinical predictors of AMR in PWH.</p><p><strong>Methods: </strong>We enrolled adult PWH hospitalised with cough <2 months in a prospective cohort in Kampala, Uganda. Participants provided expectorated sputum samples for testing by FilmArrayPN-PCR and culture. We performed drug susceptibility testing of cultured sputum isolates and detection of genetic markers of AMR on sputum by FilmArrayPN-PCR.</p><p><strong>Results: </strong>The 107 participants enrolled had a median (interquartile range) age of 40 (31 - 46) years, 50.5% (n=54/107) were female, and 74.8% (n=80/107) had recent antibiotic use. The median duration of cough was 3 (1 - 4) weeks. FilmArrayPN-PCR increased the detection of respiratory pathogens by 64.5% (95% confidence interval (CI) 54.8 - 73.1; p<0.001) and detected AMR in 25.2% (n=27/107). Baseline room air oxygen saturation <92% (adjusted odds ratio (aOR) 9.20; 95% CI 2.52 - 33.57; p=0.001) and prior antibiotic use (aOR 4.14; 95% CI 1.04 - 16.51; p=0.04) were independent predictors of AMR.</p><p><strong>Conclusion: </strong>FilmArrayPN-PCR increased the diagnostic yield of pathogens, and a low baseline oxygen saturation (<92%) and prior antibiotic use were associated with an increased risk of AMR in hospitalised PWH with CAP.</p><p><strong>Study synopsis: </strong><b>What the study adds.</b> The Biofire FilmArray Pneumonia Panel plus detected 64.5% more respiratory pathogens compared with culture, and detected antimicrobial resistance (AMR) genes in 25.2% of patients with HIV hospitalised with community-acquired pneumonia (CAP). Baseline room air oxygen saturation <92% and prior antibiotic use were associated with nine times and four times increased odds of AMR, respectively.<b>Implications of the findings.</b> Multiplex polymerase chain reaction (PCR) assays increase the speed of detection and diagnostic yield of respiratory pathogens and may be useful for diagnosis of AMR in hospitalised patients with HIV and CAP. The clinical implications of these findings should be evaluated further in prospective studies and cost-effectiveness studies to define the role of multiplex PCR tests in the patient care pathway.</p>","PeriodicalId":52847,"journal":{"name":"African Journal of Thoracic and Critical Care Medicine","volume":"31 2","pages":"e2415"},"PeriodicalIF":0.0,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12490504/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145234088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
African Journal of Thoracic and Critical Care Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1